| [1] |
Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv.
The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia
[J]. Clinical Focus, 2024, 39(1): 47-52.
|
| [2] |
Du Jiayi, Liu Lili, He Yongzhong, Tian Chuan, Lan Xiang, Ye Zhonglyu.
Clinical observation of serious adverse events in children with acute lymphoblastic leukemia during chemotherapy
[J]. Clinical Focus, 2023, 38(2): 149-154.
|
| [3] |
Li Qing, Zhong Wen, Liu Siqiang, Chen Yusheng, Li Hongru.
Meta-analysis of PD-1/PD-L1 inhibitors in the treatment of patients with non-small cell lung cancer having brain metastases
[J]. Clinical Focus, 2022, 37(5): 400-405.
|
| [4] |
Yin Lingling, Wu Wenjian, Zhu Feng.
Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: A case report and literature review
[J]. Clinical Focus, 2022, 37(11): 1025-1030.
|
| [5] |
Ye Qian, Ling Zhi, Yin Xudong.
Sarcopenia on immune checkpoint inhibitors in solid tumor patients with sarcopenia: A meta-analysis
[J]. Clinical Focus, 2022, 37(10): 889-898.
|
| [6] |
Wang Hui, Chen Man.
Flow cytometry in minimal residual disease detection of acute myeloid leukemia: current status and progress
[J]. Clinical Focus, 2021, 36(10): 889-895.
|
| [7] |
Lu Wenyi, Zhao Mingfeng.
The standard treatment of acute lymphoblastic leukemia
[J]. Clinical Focus, 2021, 36(10): 874-879.
|
| [8] |
Sun Mei1, Hou Xiaoxia2, Jin Shanquan1, Shen Feifei1, Cheng Hong1.
LGI1 antibodyrelated limbic encephalitis: a case report and literature review
[J]. Clinical Focus, 2019, 34(3): 273-275.
|
| [9] |
Mo Yijun1, Zhang Jianhua1, Yan Jun1, Lin Lina2.
Treatment of advanced squamous nonsmall cell lung cancer with programmed cell death ligand 1 inhibitors: a report of two cases and literature review
[J]. Clinical Focus, 2019, 34(3): 237-243.
|
| [10] |
Yang Jianzhua, Zhang Jinqiaob, Wang Xiaomenga, Lv Hongyanb, Sun Lixiab.
Clinical features and prognosis in patients with multiple myeloma who had extramedullary disease at diagnosis
[J]. Clinical Focus, 2018, 33(6): 490-493,497.
|
| [11] |
Ren Jinhai， Guo Xiaonan.
Clinical advances on neoplastic haematologic disorders in 2017
[J]. Clinical Focus, 2018, 33(1): 40-45.
|
| [12] |
Chen Yongquan， Yang Ting.
Current treatment strategies for refractory/relapsed Hodgkin's lymphoma
[J]. Clinical Focus, 2017, 32(12): 1022-1026.
|
| [13] |
Zhang Yusheng， Wang Yaning，He Xia.
Clinical study of docetaxel combined with oxaliplatin in advanced nonsmall cell lung cancer
[J]. Clinical Focus, 2016, 31(5): 551-553,558.
|
| [14] |
Liu Xinyan,Wei Hongyan, Dai Xianli, Liu Ying.
Clinical efficacy of chemotherapy combined with location intervened by bronchoscope in central lung cancer
[J]. Clinical Focus, 2016, 31(4): 389-391.
|
| [15] |
Li Xu;Li Hongen;Li Jingya.
A meta-analysis on the effects of regimen SOX versus FOLFOXs in treatment of advanced gastric cancer
[J]. Clinical Focus, 2015, 30(5): 512-516517.
|
